Mathieu V - Search Results

1

Le Mercier M, Fortin S, Mathieu V, Kiss R, Lefranc F. Le Mercier M, et al. Among authors: mathieu v. Brain Pathol. 2010 Jan;20(1):17-27. doi: 10.1111/j.1750-3639.2009.00270.x. Epub 2009 Apr 7. Brain Pathol. 2010. PMID: 19371355 Free PMC article. Review.

2

Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.

Lefranc F, Mijatovic T, Mathieu V, Rorive S, Decaestecker C, Debeir O, Brotchi J, Van Ham P, Salmon I, Kiss R. Lefranc F, et al. Among authors: mathieu v. Clin Cancer Res. 2004 Dec 15;10(24):8250-65. doi: 10.1158/1078-0432.CCR-04-0343. Clin Cancer Res. 2004. PMID: 15623601

3

Gastrin exerts pleiotropic effects on human melanoma cell biology.

Mathieu V, Mijatovic T, van Damme M, Kiss R. Mathieu V, et al. Neoplasia. 2005 Oct;7(10):930-43. doi: 10.1593/neo.05379. Neoplasia. 2005. PMID: 16242076 Free PMC article.

4

Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers.

Mijatovic T, Mathieu V, Gaussin JF, De Nève N, Ribaucour F, Van Quaquebeke E, Dumont P, Darro F, Kiss R. Mijatovic T, et al. Among authors: mathieu v. Neoplasia. 2006 May;8(5):402-12. doi: 10.1593/neo.05850. Neoplasia. 2006. PMID: 16790089 Free PMC article.

5

Anti-galectin compounds as potential anti-cancer drugs.

Ingrassia L, Camby I, Lefranc F, Mathieu V, Nshimyumukiza P, Darro F, Kiss R. Ingrassia L, et al. Among authors: mathieu v. Curr Med Chem. 2006;13(29):3513-27. doi: 10.2174/092986706779026219. Curr Med Chem. 2006. PMID: 17168720 Review.

6

Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model.

Mathieu V, Le Mercier M, De Neve N, Sauvage S, Gras T, Roland I, Lefranc F, Kiss R. Mathieu V, et al. J Invest Dermatol. 2007 Oct;127(10):2399-410. doi: 10.1038/sj.jid.5700869. Epub 2007 May 10. J Invest Dermatol. 2007. PMID: 17495956 Free article.

7

4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs.

Mégalizzi V, Mathieu V, Mijatovic T, Gailly P, Debeir O, De Neve N, Van Damme M, Bontempi G, Haibe-Kains B, Decaestecker C, Kondo Y, Kiss R, Lefranc F. Mégalizzi V, et al. Among authors: mathieu v. Neoplasia. 2007 May;9(5):358-69. doi: 10.1593/neo.07130. Neoplasia. 2007. PMID: 17534441 Free PMC article.

8

Neurotensin is a versatile modulator of in vitro human pancreatic ductal adenocarcinoma cell (PDAC) migration.

Mijatovic T, Gailly P, Mathieu V, De Nève N, Yeaton P, Kiss R, Decaestecker C. Mijatovic T, et al. Among authors: mathieu v. Cell Oncol. 2007;29(4):315-26. doi: 10.1155/2007/701789. Cell Oncol. 2007. PMID: 17641415 Free PMC article.

9

Evidence of galectin-1 involvement in glioma chemoresistance.

Le Mercier M, Lefranc F, Mijatovic T, Debeir O, Haibe-Kains B, Bontempi G, Decaestecker C, Kiss R, Mathieu V. Le Mercier M, et al. Among authors: mathieu v. Toxicol Appl Pharmacol. 2008 Jun 1;229(2):172-83. doi: 10.1016/j.taap.2008.01.009. Epub 2008 Jan 29. Toxicol Appl Pharmacol. 2008. PMID: 18313712

10

Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses.

Le Mercier M, Mathieu V, Haibe-Kains B, Bontempi G, Mijatovic T, Decaestecker C, Kiss R, Lefranc F. Le Mercier M, et al. Among authors: mathieu v. J Neuropathol Exp Neurol. 2008 May;67(5):456-69. doi: 10.1097/NEN.0b013e318170f892. J Neuropathol Exp Neurol. 2008. PMID: 18431251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page